Masimo (MASI) | Stock Overview & Key Data
Masimo Performance Comparison
Stock Range
Today's Range
Low: $152.92
High: $158.29
on August 15, 2025
52 Week Range
Low: $107.98
High: $194.88
on September 9, 2024
on March 3, 2025
All-Time High: $305.21 on November 15, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$8.2B
EPS
-5.08
P/E Ratio (TTM)
129.16
Forward P/E
32.36
P/B Ratio
7.82
PEG Ratio
32.36
Div. Yield
N/A
ROE
-22.37%
Beta
1.210
Debt to Equity
61.58
Financial Highlights
Profitability
Gross Margin
62.90%
Operating Margin
17.12%
Profit Margin
-21.32%
Returns and Earnings
Return on Assets (TTM)
1.84%
Return on Equity (TTM)
-22.37%
EBITDA
$145.6M
Net Income (TTM)
$-269.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$40.18
Quarterly Revenue Growth (YoY)
7.90%
Quarterly Earnings Growth (YoY)
220.60%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Masimo MASI | 8.16B Mid-cap | 4.81% | -6.07% | -0.84% | -16.24% | -9.91% | 23.04% | -2.47% | -30.71% |
| Abbott Laboratories ABT | 228.04B Mega-cap | -2.11% | -2.08% | 0.56% | -1.02% | 13.96% | 16.51% | 17.51% | 26.30% |
| Boston Scientific BSX | 152.25B Large-cap | 1.16% | -0.17% | 1.17% | -1.85% | 16.52% | 33.10% | 147.86% | 171.01% |
| Penumbra PEN | 9.69B Mid-cap | 5.18% | 5.80% | -12.37% | -5.75% | 5.51% | 32.91% | 55.85% | 8.83% |
| Globus Medical GMED | 8.36B Mid-cap | 11.00% | 4.62% | 3.18% | -28.49% | -26.65% | -14.09% | -7.38% | 12.33% |
| Bio-Rad Laboratories BIO | 7.40B Mid-cap | 8.27% | 14.51% | 21.15% | 3.63% | -11.94% | -11.79% | -43.71% | -44.55% |
Ownership & Short Interest
Insider Ownership
7.87%
Institutional Ownership
102.42%
Shares Short
3M
Short Ratio
6.08
Short % of Shares Outstanding
8.74%
Average 10-Day Volume
1M
Average 90-Day Volume
720K
Masimo Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Masimo would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MASI's 52-week high and low?
- In the last 52 weeks, Masimo reached a high of $194.88 (on March 3, 2025) and a low of $107.98 (on September 9, 2024).
- What is the market cap and P/E ratio for MASI?
- Curious about Masimo's size and valuation? Its market capitalization stands at 8.16B. When it comes to valuation, the P/E ratio (trailing twelve months) is 129.16, and the forward P/E (looking ahead) is 32.36.
- Does MASI pay dividends? If so, what's the yield?
- As for dividends, Masimo isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Masimo's main competitors or similar companies to consider before investing?
When looking at Masimo, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT228.04B Healthcare Medical Devices 16.51% 17.51% Boston Scientific
BSX152.25B Healthcare Medical Devices 33.10% 147.86% Penumbra
PEN9.69B Healthcare Medical Devices 32.91% 55.85% Globus Medical
GMED8.36B Healthcare Medical Devices -14.09% -7.38% Bio-Rad Laboratories
BIO7.40B Healthcare Medical Devices -11.79% -43.71% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Masimo Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Masimo's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -22.37%, the Debt to Equity ratio from the most recent quarter is 61.58, and its Gross Profit Margin stands at 62.90%.
- What is the recent revenue and earnings growth for MASI?
- Looking at Masimo's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.90%, and quarterly earnings saw a YoY growth of 220.60%.
- How much of MASI stock is held by insiders and institutions?
- Wondering who owns Masimo stock? Company insiders (like executives and directors) hold about 7.87% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 102.42%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.